Check how courts have cited this case. Use our free citator for the most current treatment.
No. 10373720
United States Court of Appeals for the Ninth Circuit
Murphey v. USA
No. 10373720 · Decided April 7, 2025
No. 10373720·Ninth Circuit · 2025·
FlawFinder last updated this page Apr. 2, 2026
Case Details
Court
United States Court of Appeals for the Ninth Circuit
Decided
April 7, 2025
Citation
No. 10373720
Disposition
See opinion text.
Full Opinion
NOT FOR PUBLICATION
FILED
UNITED STATES COURT OF APPEALS
APR 7 2025
FOR THE NINTH CIRCUIT MOLLY C. DWYER, CLERK
U.S. COURT OF APPEALS
JENNIFER MURPHEY, individually and No. 24-4085
on behalf of all others similarly situated,
D.C. No. 2:22-cv-01224-JJT
Plaintiff - Appellant,
v. MEMORANDUM*
UNITED STATES OF
AMERICA; MERRICK B.
GARLAND, Attorney General; ANNE
MILGRAM, Administrator of the United
States Drug Enforcement
Administration; XAVIER BECERRA,
Secretary of the Department of Health and
Human Services; KRIS MAYES, Attorney
General of the State of Arizona; ROBERT
M. CALIFF, Commissioner of Food and
Drugs, United States Food and Drug
Administration,
Defendants - Appellees.
Appeal from the United States District Court
for the District of Arizona
John Joseph Tuchi, District Judge, Presiding
Submitted April 1, 2025**
Phoenix, Arizona
*
This disposition is not appropriate for publication and is not precedent
except as provided by Ninth Circuit Rule 36-3.
**
The panel unanimously concludes this case is suitable for decision
without oral argument. See Fed. R. App. P. 34(a)(2).
Before: W. FLETCHER, FISHER***, and R. NELSON, Circuit Judges.
Plaintiff-Appellant Jennifer Murphey appeals from the district court’s final
order dismissing her first amended complaint without leave to amend. Murphey
seeks declaratory and injunctive relief for alleged constitutional and Administrative
Procedure Act (“APA”) violations of the Controlled Substances Act (“CSA”), the
Arizona Controlled Substances Act (“AZCSA”), and two international treaties
relating to drug enforcement. We have jurisdiction under 28 U.S.C. § 1291. We
review de novo a district court’s dismissal under Federal Rules of Civil Procedure
12(b)(1) and 12(b)(6). Prutehi Litekyan: Save Ritidian v. U.S. Dep’t of Airforce,
128 F.4th 1089, 1105 (9th Cir. 2025). We affirm.
We agree with the district court that Murphey has Article III standing to
bring this pre-enforcement suit as to the CSA, AZCSA, and related regulations and
criminal provisions. “In order to invoke the jurisdiction of the federal courts, a
plaintiff must establish ‘the irreducible constitutional minimum of standing,’
consisting of three elements: injury in fact, causation, and a likelihood that a
favorable decision will redress the plaintiff’s alleged injury.” Lopez v. Candaele,
630 F.3d 775, 785 (9th Cir. 2010) (quoting Lujan v. Defs. of Wildlife, 504 U.S.
555, 560 (1992)).
***
The Honorable D. Michael Fisher, United States Circuit Judge for the
Court of Appeals for the Third Circuit sitting by designation.
2
To establish a pre-enforcement injury-in-fact, Murphey must satisfy the
requirements listed in Susan B. Anthony List v. Driehaus, 573 U.S. 149 (2014).
Peace Ranch, LLC v. Bonta, 93 F.4th 482, 487 (9th Cir. 2024). “Under Driehaus,
a plaintiff demonstrates injury-in-fact by showing ‘[1] an intention to engage in a
course of conduct arguably affected with a constitutional interest, but [2]
proscribed by a statute, and [3] there exists a credible threat of prosecution
thereunder.’” Planned Parenthood Great Nw., Haw., Alaska, Ind., Ky. v.
Labrador, 122 F.4th 825, 836 (9th Cir. 2024) (alterations in original) (quoting
Driehaus, 573 U.S. at 159).
Murphey satisfies these requirements. First, she has alleged an intention to
engage in a course of conduct because she “currently” and “fully intend[s] to
continue . . . cultivating, possessing and/or using” the relevant controlled
substances. She also alleged that this course of conduct implicates her
constitutional interests. See Peace Ranch, 93 F.4th at 488 (“[T]his inquiry does
not require us to engage in a mini litigation of the claims.”). Second, the conduct
is proscribed by the CSA, AZCSA, and related regulations and criminal provisions.
Third, Murphey has demonstrated a “substantial” threat of enforcement. Driehaus,
573 U.S. at 164. “This final prong often rises or falls with the enforcing
authority’s willingness to disavow enforcement.” Peace Ranch, 93 F.4th at 490.
Neither Arizona nor federal officials have disavowed enforcement here. Having
3
established injury-in-fact, Murphey satisfies the other elements of Article III
standing. Her alleged injury is caused by the anticipated enforcement of the CSA,
AZCSA, and related regulations and criminal statutes, and it would be redressed if
a court ruled in her favor.
We also agree with the district court that Murphey’s challenges to the 1961
Single Convention on Narcotic Drugs and the 1971 Convention on Psychotropic
Substances are nonjusticiable. Murphey does not dispute that these international
treaties are non-self-executing. “Because non-self-executing treaty provisions are
not judicially enforceable, claims seeking to enforce them are nonjusticiable.”
Republic of Marshall Islands v. United States, 865 F.3d 1187, 1193 (9th Cir.
2017). Murphey also lacks standing for these claims because her injury is not
redressable. See id. at 1199. The conventions do not impose the criminal penalties
she seeks to avoid.
Finally, we agree with the district court that it lacked subject matter
jurisdiction over Murphey’s APA claim. Courts of appeals have exclusive original
jurisdiction over “all final determinations, findings, and conclusions” by the DEA
when applying the CSA. 21 U.S.C. § 877. Murphey has not explained how her
APA claim does not challenge the DEA’s “final determinations, findings, or
conclusions.”
4
On the merits, we conclude that the district court correctly dismissed
Murphey’s free speech and procedural due process claims under Rule 12(b)(6).
“To survive a motion to dismiss, a complaint must contain sufficient factual matter,
accepted as true, to state a claim to relief that is plausible on its face.” City of
Oakland v. Oakland Raiders, 20 F.4th 441, 451 (9th Cir. 2021) (quoting Ashcroft
v. Iqbal, 556 U.S. 662, 678 (2009)) (quotation marks omitted). We only address
the federal law applicable to Murphey’s claims because she does not raise any
distinct state law arguments.
Murphey failed to state a free speech claim under either the U.S.
Constitution or the Arizona Constitution. The First Amendment protects conduct
“inten[ded] to convey a particularized message” and when “in the surrounding
circumstances the likelihood was great that the message would be understood by
those who viewed it.” Spence v. Washington, 418 U.S. 405, 410–11 (1974).
Murphey has not pointed to any particularized message that she intends to convey
by using controlled substances. Her “Freedom of Thought” theory also fails.
“[T]he mere fact that . . . some human ‘utterances’ or ‘thoughts’ may be
incidentally affected does not bar the State from acting to protect legitimate state
interests.” Paris Adult Theatre I v. Slaton, 413 U.S. 49, 67 (1973).
Murphey also failed to state a procedural due process claim under either the
U.S. Constitution or the Arizona Constitution. “A procedural due process claim
5
consists of two elements: (i) deprivation by state action of a protected interest in
life, liberty, or property, and (ii) inadequate state process.” Reed v. Goertz, 598
U.S. 230, 236 (2023). Murphey has not alleged sufficient facts to support a finding
of inadequate process. It is unclear what processes Murphey believes were
constitutionally required but not provided. Murphey primarily contends that
scheduling decisions under the CSA are arbitrary and biased. But this Court has
repeatedly rejected similar constitutional challenges to cannabis scheduling.
United States v. Christie, 825 F.3d 1048, 1066 (9th Cir. 2016); United States v.
Miroyan, 577 F.2d 489, 495 (9th Cir. 1978), overruled on other grounds as
recognized by United States v. Pineda-Moreno, 688 F.3d 1087, 1090–91 (9th Cir.
2012).
AFFIRMED.
6
Plain English Summary
NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS APR 7 2025 FOR THE NINTH CIRCUIT MOLLY C.
Key Points
01NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS APR 7 2025 FOR THE NINTH CIRCUIT MOLLY C.
02GARLAND, Attorney General; ANNE MILGRAM, Administrator of the United States Drug Enforcement Administration; XAVIER BECERRA, Secretary of the Department of Health and Human Services; KRIS MAYES, Attorney General of the State of Arizona; ROB
03CALIFF, Commissioner of Food and Drugs, United States Food and Drug Administration, Defendants - Appellees.
04** The panel unanimously concludes this case is suitable for decision without oral argument.
Frequently Asked Questions
NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS APR 7 2025 FOR THE NINTH CIRCUIT MOLLY C.
FlawCheck shows no negative treatment for Murphey v. USA in the current circuit citation data.
This case was decided on April 7, 2025.
Use the citation No. 10373720 and verify it against the official reporter before filing.